INTERNATIONAL STEM CELL CORPORATION Net Income (Loss) Available to Common Stockholders, Diluted
INTERNATIONAL STEM CELL CORPORATION (ISCO) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$71.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-13
- INTERNATIONAL STEM CELL CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was -$71.00K, a 205.97% decline year-over-year.
- INTERNATIONAL STEM CELL CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $29.00K.
- INTERNATIONAL STEM CELL CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2025-06-30 was $67.00K, a 8.06% increase year-over-year.
- INTERNATIONAL STEM CELL CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2024-09-30 was -$125.00K.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|
| 2026-06-30 | -$71.00K 10-Q · filed 2026-08-13 | -$291.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $29.00K 10-Q · filed 2025-11-13 | $96.00K derived: sum of 2 quarters · filed 2026-08-13 | -$70.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $67.00K 10-Q · filed 2026-08-13 | -$127.00K 10-Q · filed 2026-08-13 | |
| 2024-09-30 | -$125.00K 10-Q · filed 2025-11-13 | -$63.00K derived: sum of 2 quarters · filed 2025-11-13 | -$220.00K 10-Q · filed 2025-11-13 |
| 2024-06-30 | $62.00K 10-Q · filed 2025-08-14 | -$95.00K 10-Q · filed 2025-08-14 | |
| 2023-09-30 | -$131.00K 10-Q · filed 2024-11-13 | $128.00K derived: sum of 2 quarters · filed 2024-11-13 | $172.00K 10-Q · filed 2024-11-13 |
| 2023-06-30 | $259.00K 10-Q · filed 2024-08-13 | $241.00K 10-Q · filed 2024-08-13 | |
| 2022-09-30 | -$343.00K 10-Q · filed 2023-11-13 | -$345.00K derived: sum of 2 quarters · filed 2023-11-13 | -$354.00K 10-Q · filed 2023-11-13 |
| 2022-06-30 | -$2.00K 10-Q · filed 2023-08-11 | -$11.00K 10-Q · filed 2023-08-11 |